Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | CES1 | P23141 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL294341 | 0.83 | ALDH1A1 (0.73) | ALDH1A1L3MBTL1MAPK1LMNASMN1; SMN2 | |
| SCHEMBL5249734 | 0.83 | ALDH1A1 (0.58) | ALDH1A1L3MBTL1MAPK1LMNASMN1; SMN2 | |
| SCHEMBL8069055 | 0.81 | ALDH1A1 (0.70) | ALDH1A1L3MBTL1MAPK1LMNASMN1; SMN2 | |
| SCHEMBL1931085 | 0.80 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MAPK1LMNASMN1; SMN2 | |
| SCHEMBL338280 | 0.80 | ALDH1A1 (0.68) | ALDH1A1L3MBTL1MAPK1LMNASMN1; SMN2 | |
| SCHEMBL1011103 | 0.80 | ALDH1A1 (0.68) | ALDH1A1L3MBTL1MAPK1LMNASMN1; SMN2 | |
| SCHEMBL12586386 | 0.79 | ALDH1A1 (0.61) | ALDH1A1L3MBTL1MAPK1CES1LMNA | |
| SCHEMBL5751558 | 0.78 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1MAPK1LMNASMN1; SMN2 | |
| SCHEMBL3296385 | 0.78 | ALDH1A1 (0.57) | ALDH1A1L3MBTL1MAPK1CES1LMNA | |
| SCHEMBL27712861 | 0.78 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1MAPK1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250234865-A1 | Additive Composition for Antifouling Coatings | Arxada, LLC | 2025-07-24 | — | — | US | disclosed |
| EP-4402215-A1 | ADDITIVE COMPOSITION FOR ANTIFOULING COATINGS | Arxada, LLC (US) | 2024-07-24 | — | — | EP | disclosed |
| WO-2023064524-A1 | ADDITIVE COMPOSITION FOR ANTIFOULING COATINGS | Arxada, LLC (US) | 2023-04-20 | — | — | WO | disclosed |
| EP-3707143-B9 | NEW ANALOGS AS ANDROGEN RECEPTOR AND GLUCOCORTICOID RECEPTOR MODULATORS | ONCOSTELLAE S L (ES) | 2023-04-12 | — | — | EP | disclosed |
| US-20230019988-A1 | Compositions for Antifouling Protection | Arxada Switzerland AG (CH) | 2023-01-19 | — | — | US | disclosed |
| EP-3707143-B1 | NEW ANALOGS AS ANDROGEN RECEPTOR AND GLUCOCORTICOID RECEPTOR MODULATORS | ONCOSTELLAE S L (ES) | 2022-12-28 | — | — | EP | disclosed |
| US-11453660-B2 | Androgen receptor and glucocorticoid receptor modulators | ONCOSTELLAE, S.L. | 2022-09-27 | — | — | US | disclosed |
| CN-114026181-A | Composition for antifouling protection | 阿尔萨达股份公司 | 2022-02-08 | — | — | CN | disclosed |
| EP-3856852-A1 | COMPOSITIONS FOR ANTIFOULING PROTECTION | Lonza Solutions AG (CH) | 2021-08-04 | — | — | EP | disclosed |
| WO-2021113564-A1 | COMPOSITIONS FOR ANTIFOULING PROTECTION | LONZA SOLUTIONS AG (CH) | 2021-06-10 | — | — | WO | disclosed |
| US-6893861-B1 | Method for producing trifluoro-3(r)-hydroxybutyric acid derivatives | LONZA AG (CH) | 2005-05-17 | — | — | US | disclosed |
| US-20020147222-A1 | Dihydropyridine derivatives | AJINOMOTO CO. INC (JP) | 2002-10-10 | — | — | US | disclosed |
| US-6380134-B1 | USED FOR CONTROLLING WEEDS | SYNGENTA CROP PROTECTION, INC. | 2002-04-30 | — | — | US | disclosed |
| EP-1191021-A1 | DIHYDROPYRIDINE DERIVATIVE | Ajinomoto Co., Inc. (JP) | 2002-03-27 | — | — | EP | disclosed |
| EP-1084117-A2 | NOVEL HERBICIDES | Novartis AG (CH) | 2001-03-21 | — | — | EP | disclosed |
| EP-1054974-A1 | METHOD FOR PRODUCING TRIFLUORO-3(R)-HYDROXYBUTYRIC ACID DERIVATIVES | Lonza AG (CH) | 2000-11-29 | — | — | EP | disclosed |
| WO-1999052892-A2 | NOVEL HERBICIDES | NOVARTIS AG (CH) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999042590-A1 | METHOD FOR PRODUCING TRIFLUORO-3(R)-HYDROXYBUTYRIC ACID DERIVATIVES | LONZA AG (CH) | 1999-08-26 | — | — | WO | disclosed |
| US-4396626-A | (1-METHYL-4-TRIFLUOROMETHYL-5-ARYLCARBONYL-4-PYRRYL)ALKANOIC ACID OR DERIVATIVE; ANALGESIC, ANTIINFLAMMATORY | BEECHAM GROUP LIMITED (GB) | 1983-08-02 | — | — | US | disclosed |
| EP-0049999-A2 | Cyclic compounds and their preparation and use | BEECHAM GROUP PLC (GB) | 1982-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250234865-A1 | Additive Composition for Antifouling Coatings | PSPH, PHOSPHO1, CFD | ALDH1A1 1165/4885L3MBTL1 2184/4885MAPK1 4052/4885 |
| US-11453660-B2 | Androgen receptor and glucocorticoid receptor modulators | AR, NR5A1, NR3C1 | ALDH1A1 1496/4885L3MBTL1 4731/4885MAPK1 963/4885 |
| US-20020147222-A1 | Dihydropyridine derivatives | CACNA1B, CACNA1D, CACNA1C | ALDH1A1 2039/4885L3MBTL1 3370/4885MAPK1 2345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.